Skip to main content

CSL Behring Australia

Our portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema.
https://myexport.au/media/com_jbusinessdirectory/pictures/item/www_cslbehring_com_au.png
  • Details

Screen-Shot-2023-06-21-at-92542-am

Type
Business Organisation